Use of efaroxan for producing medicine for treating huntington 's disease
US6153638A · kind A · utility
1Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 1999 |
| Grant date | Nov 28, 2000 |
| Priority date | — |
| Expiry date | Feb 12, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns the use of efaroxan or therapeutically-acceptable salts, in its racemic form or in the form of an optically-active isomer, for treating Huntington's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.